Prognostic impact of hepatitis B or C on intrahepatic cholangiocarcinoma
Jung Woong Seo, Byung Soo Kwan, Young Koog Cheon, Tae Yoon Lee, Chan Sup Shim, So Young Kwon, Won Hyeok Choe, Byung Chul Yoo, Jeong Min Yoon, Jung Hoon Lee
Korean J Intern Med. 2020;35(3):566-573. Published online 2020 Jan 10 DOI: https://doi.org/10.3904/kjim.2018.062
Citations to this article as recorded by 
MRI for Hepatitis B‐Associated Intrahepatic Cholangiocarcinoma: A Multicenter Comparative Study
Ruofan Sheng, Heqing Wang, Yunfei Zhang, Wei Sun, Kaipu Jin, Yongming Dai, Weiguo Zhang, Mengsu Zeng, Jianjun Zhou
Journal of Magnetic Resonance Imaging.2024; 59(3): 1093. CrossRef
The Integrated Prediction of Clinical and Pathological Factors on the Prognosis of Intrahepatic Cholangiocarcinoma
Guoliang Chen, Song Li, Adong Xia, Yuelong Xing, Wenbo Liang
The American Surgeon™.2024;[Epub] CrossRef
Hepatitis B virus-related intrahepatic cholangiocarcinoma originates from hepatocytes
Zimin Song, Shuirong Lin, Xiwen Wu, Xiaoxue Ren, Yifan Wu, Haoxiang Wen, Baifeng Qian, Haozhong Lin, Yihao Huang, Chenfeng Zhao, Nian Wang, Yan Huang, Baogang Peng, Xiaoxing Li, Hong Peng, Shunli Shen
Hepatology International.2023; 17(5): 1300. CrossRef
A comparative study of clinicopathological and imaging features of HBV-negative and HBV-positive intrahepatic cholangiocarcinoma patients with different pathologic differentiation degrees
Xiaoli Huang, Dan Yu, Xintao Gu, Jiansun Li, Jiaqi Chen, Yuanqiang Zou, Jinyuan Liao
Scientific Reports.2023;[Epub] CrossRef
Results of Intrahepatic Cholangiocarcinoma Resections: a Single-Center Analysis
Kutay Saglam, Yusuf Murat Bag, Zafer Bilen, Burak Isik, Cemalettin Aydin, Sezai Yilmaz
Journal of Gastrointestinal Cancer.2022; 53(4): 1034. CrossRef
Prognostic analysis of radical resection for iCCAphl and iCCApps: A retrospective cohort study
Zetao Yu, Qingqiang Ni, Hongtao Jia, Hengjun Gao, Faji Yang, Huaqiang Zhu, Fangfeng Liu, Jianlu Wang, Xu Zhou, Hong Chang, Jun Lu
Frontiers in Oncology.2022;[Epub] CrossRef
Immune Microenvironment and Immunotherapeutic Management in Virus-Associated Digestive System Tumors
Panagiotis Sarantis, Eleni-Myrto Trifylli, Evangelos Koustas, Kostas A. Papavassiliou, Michalis V. Karamouzis, Athanasios G. Papavassiliou
International Journal of Molecular Sciences.2022; 23(21): 13612. CrossRef
Anatomical Resection Improved the Outcome of Intrahepatic Cholangiocarcinoma: A Propensity Score Matching Analysis of a Retrospective Cohort
Chao Wang, Pingcuo Ciren, Awang Danzeng, Yong Li, Cheng-Long Zeng, Zhi-Wei Zhang, Zhi-Yong Huang, Yi-Fa Chen, Wan-Guang Zhang, Bi-Xiang Zhang, Bin-Hao Zhang, Xiao-Ping Chen, Shuang-zheng Jia
Journal of Oncology.2022; 2022: 1. CrossRef
Comparison of ICC patients with hepatitis B infection to those with no major risk factors for HCC
Kwang Min Kim, Ji Eun Na, Sang Goon Shim, Dong Hyun Sinn
HPB.2021; 23(6): 945. CrossRef
WIP1 Inhibition by GSK2830371 Potentiates HDM201 through Enhanced p53 Phosphorylation and Activation in Liver Adenocarcinoma Cells
Chiao-En Wu, Chen-Yang Huang, Chiao-Ping Chen, Yi-Ru Pan, John Wen-Cheng Chang, Jen-Shi Chen, Chun-Nan Yeh, John Lunec
Cancers.2021; 13(15): 3876. CrossRef
Viruses in Cancers of the Digestive System: Active Contributors or Idle Bystanders?
Martin Marônek, René Link, Giovanni Monteleone, Roman Gardlík, Carmine Stolfi
International Journal of Molecular Sciences.2020; 21(21): 8133. CrossRef